Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

Also called NCT04696120

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 200 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT04696120
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04696120. Randomized; quadruple masking; primary purpose treatment. Start 2021-03-02 (anticipated); primary completion 2022-08-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effects of APIXaban on BRAIN Protection in Patients With Sinus Rhythm and Heart Failure: APIXBRAIN-HF Trial
Condition
Heart Failure
Condition
Sinus Rhythm
Condition
Cerebrovascular Disease
Intervention (Drug)
Apixaban
Intervention (Drug)
Placebo
Lead sponsor
Korea University Guro Hospital (class: other)
Collaborator
Dt&Sanomedics (class: industry)

Record details

Record id
cardio:ct-nct04696120
Content hash
3b69a9202a571461872d992338c8708350bb1d8bbe848cb391f49effdf6e1b56